Kyphoplasty denied as not FDA-approved for this use by Medicare?

Medicare's specific coverage criteria for kyphoplasty are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Medicare Denied This Claim as "Not FDA-Approved"

Balloon kyphoplasty is a minimally invasive surgical procedure — not a drug — so FDA device clearance is the relevant regulatory standard rather than drug approval. Medicare and its contractors occasionally issue denials using "not FDA-approved" language when coverage documentation is incomplete or when a claim is miscoded. The procedure does hold FDA 510(k) clearance as a Class II device, but Medicare coverage turns on whether the Local Coverage Determination (LCD) or National Coverage Determination (NCD) conditions are met, not FDA status alone. A denial worded this way is nearly always appealable and frequently reversed with the right documentation.

## Your Federal Appeal Rights

Medicare beneficiaries have a structured, time-limited appeal pathway:

• Redetermination — filed with the Medicare Administrative Contractor (MAC) within 120 days of the initial denial.
• Reconsideration — filed with a Qualified Independent Contractor (QIC) within 180 days of the redetermination.
• ALJ Hearing, Medicare Appeals Council, and Federal Court — three additional levels if earlier levels are unsuccessful.
• Expedited review — available when the standard timeline would seriously jeopardize your health.

All Medicare appeal rights and deadlines are printed on your Medicare Summary Notice (MSN) or Explanation of Benefits (EOB).

## What to Gather Before You Appeal

Build a documentation package that directly rebuts the "not FDA-approved" framing:

1. Operative and procedure report confirming the exact procedure performed and the device used, including the manufacturer's FDA 510(k) clearance number. 2. Diagnosis confirmation — imaging (CT or MRI) confirming a vertebral compression fracture, the fracture level, and the date of injury. 3. Clinical severity documentation — chart notes describing pain severity, functional limitations, and neurological status. 4. Prior-treatment history — a chronological record of conservative treatments tried, duration, and documented outcomes. 5. Prescriber medical-necessity letter — a signed letter from the treating surgeon explaining why kyphoplasty was indicated, why conservative care was insufficient, and how the patient's clinical presentation meets the applicable coverage criteria. 6. Applicable coverage policy — obtain the current Medicare LCD for vertebral augmentation from the MAC website. Copy each coverage criterion, then provide the specific chart fact that satisfies it.

## Criteria-Mapping Structure

Attach a one-page "coverage criteria matrix" to your appeal:

| Coverage Requirement (from LCD) | Supporting Documentation | |---|---| | Diagnosis of vertebral compression fracture confirmed by imaging | Radiology report, date, level | | Fracture is painful and refractory to conservative management | Chart notes, prior treatment log | | Procedure performed within the timeframe specified in the LCD | Operative date vs. fracture date | | Device used holds appropriate FDA clearance | Device sticker or manufacturer documentation |

Cite the specific LCD number and version you are responding to. This structured rebuttal converts a vague "not approved" denial into a documented clinical argument.